Try our Advanced Search for more refined results

September 13, 2007

Santarus Inc. et al v. Par Pharmaceutical Inc.

Track this case

Case Number:

1:07-cv-00551

Court:

Delaware

Nature of Suit:

Patent

Judge:

Gregory M. Sleet

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 22, 2014

    CORRECTED: Par Pays $100M To Settle Suit Over Generic Heartburn Drug

    Par Pharmaceutical Cos. has agreed to pay $100 million to Salix Pharmaceuticals Inc. unit Santarus Inc. to resolve claims Par's generic version of the heartburn drug Zegerid infringed Santarus' patents, according to a Monday filing with the U.S. Securities and Exchange Commission. Correction: An earlier story mischaracterized the ownership of the patents. The error has been corrected.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login